NASDAQ NMS - GLOBAL MARKET · ACON
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Aclarion Inc

Aclarion Inc

Health Care
$2.35
Card
Relationship Map

Follow $ACON

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $ACON by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
ACON
Aclarion Inc
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

49/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 6 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ACON moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ACON catalysts
About Aclarion Inc
SERVICES-MEDICAL LABORATORIES
Listed since
2022
Employees
11
Country
US

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.35
Last session
Day high
$2.35
Last session
Day low
$2.35
Last session
Previous close
$2.35
52W high
$9.69
-75.75% from high
52W low
$2.02
4% of range
Market cap
$6.8M
EPS
$-8.1400
Beta
0.50
Shares out
2.9M
Avg volume
47.2K
VWAP
$2.35
Last session
Price history computed in-house
1W
-3.69%
1M
-3.69%
3M
-17.37%
1Y
-73.63%
YTD
-48.91%
SMA 50 $2.45 · below
SMA 200 $3.14 · below
52W position 4%

ACON overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading ACON Form 4 filings
Public disclosures

Congress activity in ACON

Congress disclosures unavailable.

Federal contracts

ACON contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ACON in this window.
Lobbying spend

ACON lobbying filings, year to date.

Registered lobbying filings matched to Aclarion Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ACON in this window.
Loading news for ACON
Analyst ratings
Sovereign unlock shows live analyst consensus for ACON.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.